Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 69 5
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
CoronaVac Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021 4 1
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/24/2021 7 2
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Mar/08/2021 15 2
N-acetylcysteine Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Mar/06/2021 2 1
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Verteporfin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/09/2020 2 0
MVC-COV1901 Potential treatment - pre-clinical evidence Experimental Vaccine Nov/29/2020 2 0